Research News and Research

RSS

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P."

11 Feb 2011

First 7 stem cell lines grown at UMMS Human Stem Cell Bank ready for global distribution

The first seven stem cell lines grown and banked at the University of Massachusetts Medical School's Human Stem Cell Bank are ready for worldwide distribution to researchers working on discovering new therapeutic treatments for diseases such as cancer, juvenile diabetes, Alzheimer's and Parkinson's, among others.

11 Feb 2011

GOP Reps. grill CMS Chief Berwick about health reform law, earlier remarks on British system

Republicans on the US House Committee on Ways and Means this morning pounded Donald Berwick, administrator for the Centers for Medicare and Medicaid Services, on the effects of the new health care law on seniors, and Berwick's past statements in praise of the publicly-funded British health care system.

11 Feb 2011

RF-induced heat therapy could help treat common parasitic skin infection

Scientists are hoping that heat therapy could eventually replace a complex drug regimen as the first-line treatment of a parasitic skin infection common in tropical and subtropical regions of the world.

11 Feb 2011

New perspectives challenge long-held beliefs about impact of saturated fatty acids on risk of cardiovascular disease

For generations, the consumption of dairy products has been positively associated with the health and wellness of families and communities. Nevertheless, the recent shift in dietary trends has focused on "what not to eat" instead of emphasizing "what to eat," resulting in demonizing the naturally occurring fats in dairy, while overlooking its many essential nutrients.

11 Feb 2011

Anacor, Medicis collaborate to discover and develop boron-based treatment for acne

Anacor Pharmaceuticals, Inc. and Medicis Pharmaceutical Corporation today announced that the two companies have entered into a research and development agreement to discover and develop boron-based small molecule compounds directed against a target for the potential treatment of acne.

11 Feb 2011

Cancer cells 'addicted' to self-preservation process

A team of investigators at The Cancer Institute of New Jersey (CINJ); Rutgers, The State University of New Jersey; and Princeton University, have determined that cancer cells are "addicted" to a self-preservation process known as autophagy. They also showed that the inhibition of that process could prove to be a valuable treatment approach for aggressive cancers. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

11 Feb 2011

Richard J. Fasenmyer Foundation awards $3M to Cleveland physicians for AIDS research

A three-year, $3 million gift from the Richard J. Fasenmyer Foundation will fund research by a pair of Cleveland physicians into HIV and the body's response in autoimmune diseases.

11 Feb 2011

TargetCancer awards significant grant for research into rare cancer of the bile duct

TargetCancer, a non-profit organization dedicated to funding research for rare and lesser known cancers, has awarded a significant grant to a leading researcher of gastrointestinal cancers and has established research fellowships through Harvard Medical School.

11 Feb 2011

New trial tests surgery for Type 2 diabetes

A new clinical trial at NewYork-Presbyterian Hospital/Weill Cornell Medical Center is among the first to test surgery specifically for Type 2 diabetes. The aim of the study is to understand whether surgery can control diabetes, as well or even better than the best medical treatment available today. This is the first study of its kind open to patients who are overweight or mildly obese.

11 Feb 2011

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem-, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

11 Feb 2011

Seven-year study demonstrates clear benefits of fetal surgery to treat spina bifida in babies

Results of a landmark, seven-year National Institutes of Health-funded trial, Management of Myelomeningocele Study (MOMS), demonstrate clear benefit for babies who undergo fetal surgery to treat spina bifida, the most common birth defect in the central nervous system.

11 Feb 2011

Viral infection of Leishmania leads to increased pathogenicity

A parasite and a virus may be teaming up in a way that increases the parasite's ability to harm humans, scientists at the University of Lausanne in Switzerland and Washington University School of Medicine in St. Louis report this week in Science.

11 Feb 2011

Minnesota makes progress in reducing tobacco usage and exposure to secondhand smoke

Findings from the latest Minnesota Adult Tobacco Survey (MATS), published today in the Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, show that Minnesota is continuing to make progress in reducing tobacco use and exposure to secondhand smoke. The study is the most thorough and accurate source of information about tobacco use in Minnesota.

11 Feb 2011

Study finds too low drug concentrations used for treatment of children with TB

The realization of medically treating different children uniquely may start with one of the deadliest diseases in existence: tuberculosis.

11 Feb 2011

African leaders meet in Rwanda to discuss capacity building

A two-day summit of the African Capacity Building Foundation (ACBF) in the Rwandan capital, Kigali, concluded on Wednesday with African leaders calling for stronger "efforts in building capacity that goes beyond achieving the Millennium Development Goals (MDGs) target of 2015," the New Times reports.

11 Feb 2011

£160,000 award to devise anti-microbial collar to prevent bacterial infections associated with broken bones

Orthopaedic experts at The University of Nottingham are hoping to reduce the rate of infections that often occur in the pinning of broken bones by developing a special collar to counter dangerous microbes.

11 Feb 2011

Perrigo to settle patent litigation relating to Minoxidil foam

Perrigo Company today announced that it has agreed to settle its Hatch-Waxman litigation relating to Minoxidil foam brought by Stiefel Research Australia Pty. Ltd., a GSK Company. Under the terms of the settlement, Perrigo can launch in the U. S., a generic version of Men's Rogaine® Foam on March 1, 2012, or earlier under certain circumstances.

11 Feb 2011

Family planning funds targeted by GOP

The new Congress also continues to be embroiled in battles surrounding the issue of abortion restrictions, which GOP house lawmakers have made a priority.

11 Feb 2011

Kraft Foods announces launch of new gum containing vitamins B6, B12

Great taste, long lasting, and a new boost of flavor. Kraft Foods, the maker of Stride, The Ridiculously Long Lasting Gum, today announced the launch of Stride SPARK, a new gum containing vitamins B6 and B12.

11 Feb 2011

Research News and Research

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

First 7 stem cell lines grown at UMMS Human Stem Cell Bank ready for global distribution

GOP Reps. grill CMS Chief Berwick about health reform law, earlier remarks on British system

RF-induced heat therapy could help treat common parasitic skin infection

New perspectives challenge long-held beliefs about impact of saturated fatty acids on risk of cardiovascular disease

Anacor, Medicis collaborate to discover and develop boron-based treatment for acne

Cancer cells 'addicted' to self-preservation process

Richard J. Fasenmyer Foundation awards $3M to Cleveland physicians for AIDS research

TargetCancer awards significant grant for research into rare cancer of the bile duct

New trial tests surgery for Type 2 diabetes

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Seven-year study demonstrates clear benefits of fetal surgery to treat spina bifida in babies

Viral infection of Leishmania leads to increased pathogenicity

Minnesota makes progress in reducing tobacco usage and exposure to secondhand smoke

Study finds too low drug concentrations used for treatment of children with TB

African leaders meet in Rwanda to discuss capacity building

£160,000 award to devise anti-microbial collar to prevent bacterial infections associated with broken bones

Perrigo to settle patent litigation relating to Minoxidil foam

Family planning funds targeted by GOP

Kraft Foods announces launch of new gum containing vitamins B6, B12

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News